Abstract | RATIONALE: Cancer stem cell (CSC) theory has drawn much attention, with evidence supporting the contribution of stem cells to tumor initiation, relapse, and therapy resistance. OBJECTIVES: To screen drugs that target CSCs to improve the current treatment outcome and overcome drug resistance in patients with lung cancer. METHODS: MEASUREMENTS AND MAIN RESULTS: CONCLUSIONS:
|
Authors | Chi-Tai Yeh, Alexander T H Wu, Peter M-H Chang, Kuan-Yu Chen, Chia-Ning Yang, Shuenn-Chen Yang, Chao-Chi Ho, Chun-Chi Chen, Yu-Lun Kuo, Pei-Ying Lee, Yu-Wen Liu, Chueh-Chuan Yen, Michael Hsiao, Pei-Jung Lu, Jin-Mei Lai, Liang-Shun Wang, Chih-Hsiung Wu, Jeng-Fong Chiou, Pan-Chyr Yang, Chi-Ying F Huang |
Journal | American journal of respiratory and critical care medicine
(Am J Respir Crit Care Med)
Vol. 186
Issue 11
Pg. 1180-8
(Dec 01 2012)
ISSN: 1535-4970 [Electronic] United States |
PMID | 23024022
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antipsychotic Agents
- Quinazolines
- Trifluoperazine
- Gefitinib
|
Topics |
- Animals
- Antipsychotic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Carcinoma, Non-Small-Cell Lung
(drug therapy, pathology)
- Cell Proliferation
(drug effects)
- Disease Models, Animal
- Drug Resistance, Neoplasm
- Gefitinib
- Lung Neoplasms
(drug therapy, pathology)
- Mice
- Mice, Inbred NOD
- Mice, SCID
- Neoplastic Stem Cells
(drug effects)
- Quinazolines
(pharmacology)
- Random Allocation
- Sensitivity and Specificity
- Trifluoperazine
(pharmacology)
- Tumor Cells, Cultured
(drug effects)
|